Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001178913-22-004054)

Filing Details

Accession Number:
0001178913-22-004054
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-15 16:13:24
Reporting Period:
2022-11-11
Accepted Time:
2022-11-15 16:13:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1638097 Entera Bio Ltd. ENTX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1909822 Dana Yaacov-Garbeli Kiryat Hadassah
Minrav Building, 5Th Floor
Jerusalem L3 9112002		 Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value Nis 0.0000769 Per Share Acquisiton 2022-11-11 30,000 $0.52 30,000 No 4 P Indirect By A2Z Counseling Ltd.
Ordinary Shares, Par Value Nis 0.0000769 Per Share Acquisiton 2022-11-14 26,580 $0.54 56,580 No 4 P Indirect By A2Z Counseling Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By A2Z Counseling Ltd.
No 4 P Indirect By A2Z Counseling Ltd.
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.50 to $0.54, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. These shares are owned by A2Z Counseling Ltd. of which the Reporting Person's owns a 33.33% interest and has effective control over voting and disposition of the shares. The Reporting Person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.53 to $0.54, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.